MARINUS PHARMACEUTICALS INC (MRNS)

US56854Q2003 - Common Stock

0.5361  0 (-0.35%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
31.47M30.99M25.48M15.35M1.72M
Cost Of Goods
3.09M1.93M1.51M1.48MN/A
Gross Profit
28.37M29.05M23.97M13.87MN/A
Operating Expenses
151.00M160.54M136.76M110.80M69.66M
Research and Development
87.73M99.39M79.91M73.52M51.11M
Selling, General, and Administrative Expenses
63.27M61.15M56.85M37.28M18.55M
Operating Income
-122.62M-131.49M-112.79M-95.45M-67.94M
Interest Income/Expense
-12.19M-8.78M-8.32M-2.50M500.00K
Other Income/Expense
271.00K1.42M-1.90M860.00K-40.00K
Non Recurring Items
N/A-100.00K-800.00K-1.68MN/A
Income Before Taxes
-140.49M-142.94M-16.43M-98.78M-67.48M
Income Tax
N/A-1.54M3.39MN/AN/A
Net Income
-140.49M-141.41M-19.82M-98.78M-76.36M
EBITDA
-122.10M-130.93M-112.37M-95.09M-67.61M
 
Per Share Data
EPS Diluted Total Ops
-2.47-2.63-0.51-2.69-2.80
Non GAAP EPS
-2.44-2.63-3.28-2.69-2.58
 
Statistics
Gross Profit Margin
90.17%93.76%94.07%90.36%N/A
Profit Margin
-446.49%-456.31%-77.79%-643.52%-4439.53%
Operating Profit Margin
-389.70%-424.30%-442.66%-621.82%-3950.00%

All data in USD

Charts